概括
基本高血压与左心室 (LV) 质量显著相关. 抗高血压疗法有效降低高血压患者的血压和LV质量.
科学领域:
- 心脏病学 心脏病学
- 高血压研究 高血压研究
- 诊断成像 诊断成像 诊断成像
背景情况:
- 基本高血压是一种与心血管并发症相关的常见疾病.
- 左心室 (LV) 缩是高血压患者心血管事件的重要预测因素.
- 心声图是评估心脏结构和功能的关键工具.
研究的目的:
- 在患有基本高血压的患者中研究血压和左心室质量之间的关系.
- 评估抗高血压治疗对血压和 LV 质量的影响.
主要方法:
- 使用M模式回声心脏学和持续的动脉内门诊血压监测.
- 左心室质量指数是从心声回声图数据计算出来的.
- 随访患者进行了重复心声图和血压测量.
主要成果:
- 平均24小时缩血压显示与心声图LV质量有显著的相关性.
- 与未接受治疗的患者相比,抗高血压治疗导致血压和LV质量指数显著降低.
- 在接受治疗的组中,观察到系统血压降低和LV质量指数之间存在强烈的相关性.
结论:
- 系统性血压在左心室缩的发病过程中起着至关重要的作用.
- 在心声学上评估的LV质量的变化与高血压个体的血压变化相关.
- 抗高血压治疗可以逆转与高血压相关的心脏结构变化.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...


